Cancer BiologybioRxiv
A novel antagonist of the CCL5/CCR5 axis suppresses the tumor growth and metastasis of triple-negative breast cancer by CCR5-YAP1 regulation.
Ling Chen, Guiying Xu, Xiaoxu Song…·Jing Yu
This study identifies verteporfin as a potent CCL5/CCR5 axis antagonist that suppresses TNBC tumor growth and metastasis through CCR5-YAP1 regulation.
DOI 10.1016/j.canlet.2024.216635